Semaglutide mkt settles into steady growth six months after patent expiry | Industry News
Six months after semaglutide lost patent protection in India, generic brands account for about 74 per cent of…
Generic Ozempic, Mounjaro and GLP-1 market in India: why tirzepatide still leads
When cheaper generic versions of semaglutide – originally developed by Danish drugmaker Novo Nordisk and runaway success under…